217 related articles for article (PubMed ID: 15102368)
1. New tools for antigen delivery to the MHC class I pathway.
Morón G; Dadaglio G; Leclerc C
Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
3. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules.
Monu N; Trombetta ES
Curr Opin Immunol; 2007 Feb; 19(1):66-72. PubMed ID: 17157489
[TBL] [Abstract][Full Text] [Related]
5. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
6. The cross-priming pathway: a portrait of an intricate immune system.
Basta S; Alatery A
Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
[TBL] [Abstract][Full Text] [Related]
7. The processing of antigens delivered as DNA vaccines.
Howarth M; Elliott T
Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
9. Toward a molecular explanation for cross-presentation of antigens to the immune system.
Khor B; Makar RS
Transfus Med Rev; 2008 Jul; 22(3):188-201. PubMed ID: 18572095
[TBL] [Abstract][Full Text] [Related]
10. Improving DNA vaccine potency via modification of professional antigen presenting cells.
Hung CF; Wu TC
Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
[TBL] [Abstract][Full Text] [Related]
11. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.
Shen L; Rock KL
Curr Opin Immunol; 2006 Feb; 18(1):85-91. PubMed ID: 16326087
[TBL] [Abstract][Full Text] [Related]
12. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
Segura E; Villadangos JA
Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
[TBL] [Abstract][Full Text] [Related]
13. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
Hung CF; Yang M; Wu TC
Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
[TBL] [Abstract][Full Text] [Related]
14. New understanding of immunological mechanisms.
Saalmüller A
Vet Microbiol; 2006 Oct; 117(1):32-8. PubMed ID: 16701965
[TBL] [Abstract][Full Text] [Related]
15. New approaches in vaccine development.
Leclerc C
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
[TBL] [Abstract][Full Text] [Related]
16. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications.
Wilson NS; Villadangos JA
Adv Immunol; 2005; 86():241-305. PubMed ID: 15705424
[TBL] [Abstract][Full Text] [Related]
17. Novel protein toxin-based strategy for development of cytotoxic T lymphocyte vaccines.
Wiedłocha A
Arch Immunol Ther Exp (Warsz); 1998; 46(6):341-6. PubMed ID: 9883312
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
[TBL] [Abstract][Full Text] [Related]
19. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
[TBL] [Abstract][Full Text] [Related]
20. Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses.
Kwon YJ; Standley SM; Goodwin AP; Gillies ER; Fréchet JM
Mol Pharm; 2005; 2(1):83-91. PubMed ID: 15804181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
